Study Explores In Vivo Role of Ubiquinone in Mouse Model

This article originally appeared here.
Share this content:
Study Explores In Vivo Role of Ubiquinone in Mouse Model
Study Explores In Vivo Role of Ubiquinone in Mouse Model

WEDNESDAY, March 11, 2015 (HealthDay News) -- Ubiquinone (UQ) does not act as an antioxidant in vivo, and partial restoration of UQ levels and mitochondrial function can reverse severe disease phenotypes and shortened lifespan, according to an experimental study published online March 6 in Nature Communications.

Noting that UQ has been implicated in mitochondrial electron transport, superoxide generation, and as a membrane antioxidant, Ying Wang, M.D., from McGill University in Montreal, and colleagues present a mouse model in which UQ biosynthesis can be interrupted and partially restored at will.

The researchers found that, in vivo, UQ did not act as an antioxidant, and its requirement for electron transport was lower than expected, even in mitochondria-rich organs. Severely depressed mitochondrial function due to UQ depletion did not acutely impair heart function. Furthermore, severe disease phenotypes and shortened lifespan could be reversed on partial restoration of UQ levels and mitochondrial function.

"This observation strongly suggests that the irreversible degenerative phenotypes that characterize ageing are not secondarily caused by the gradual mitochondrial dysfunction that is observed in aged animals," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »